Aegon Ltd. vs Heron Therapeutics Inc — how do they compare? Aegon Ltd. trades at $9.4 (market cap $14.16B), while Heron Therapeutics Inc trades at $0.32 (market cap $63.41M). The key difference: Aegon Ltd. is far larger — about 223.3× Heron Therapeutics Inc's market cap, and Aegon Ltd. pays a 4.9% dividend while Heron Therapeutics Inc pays none. Which is the better fit depends on your goals.
| AEG | HRTX | |
|---|---|---|
Market Cap | $14.16B | $63.41M |
Sector | Financials | Health |
52-Week High | $9.53 | $1.49 |
52-Week Low | $6.79 | $0.32 |
Enterprise Value | $15.31B | $161.31M |
Dividend Yield | 4.9% | — |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Heron Therapeutics (HRTX) trades at $0.49, down 1.64% today, with a bearish technical signal from moving averages. The company reported Q2 2026 revenue of $37.7M but missed earnings expectations with a $0.03 loss per share. Despite negative net income margins, HRTX maintains strong analyst support with 94.7% buy ratings. Recent news highlights patent litigation developments and quarterly earnings underperformance.
HRTX faces significant fundamental challenges with persistent losses and declining revenue projections, though analyst consensus remains overwhelmingly bullish. Investment opportunity exists if the company can achieve profitability and meet growth targets, but risks include ongoing operational losses, competitive pressures, and execution challenges in the biotechnology sector.
Trailing returns across standard periods
Latest headlines on both assets
Aegon is a Netherlands-headquartered insurance company with core operations that stretch across the U.S., Netherlands, and United Kingdom. The business also holds peripheral ventures in Spain, Portugal, Brazil, and China.
Read more on AEG →Heron Therapeutics is a commercial-stage biotechnology company focused on improving patient care. It develops best-in-class medicines for pain management and cancer care to address unmet medical needs.
Read more on HRTX →